Use of Continuous Glucose Monitoring in Pump Therapy Sensor Augmented Pump or Automated Insulin Delivery in Different Age Groups (0.5 to <26 Years) With Type 1 Diabetes From 2018 to 2021: Analysis of the German/Austrian/Swiss/Luxemburg Diabetes Prospective Follow-up Database Registry
Authors' conclusion
In recent years, we found an increasing use of new diabetes technologies and an improvement in metabolic control (TiR) across all age groups.
Study context
- Population
- People with T1D aged 0.5 to <26 years treated in 416 diabetes centers (Germany, Austria, Luxemburg, Switzerland), January 2018 to December 2021
- Participants
- 46,043 people416 centers
- Exposure
- Use of sensor augmented pump (SAP) and automated insulin delivery (AID) over time, by age group
- Outcome
- Use of SAP (insulin pump + continuous glucose monitoring (CGM) ≥90 days, no automated dose adjustment) and AID (HCL or LGS/PLGS)
- Follow-up
- 2018 to 2021
Methodological detailsmulticentre, patient registry (DPV)
- Multicentre
- Patient registry (DPV)
Main finding
As reported in the abstract
- SAP use, 2018 to 2021 (significant increase)
- 28.7% to 32.9%
- AID use, 2018 to 2021 (significant increase)
- 3.5% to 16.6%
- Group A (<7 years) SAP use, most frequent
- 38.8%-40.2%
- Group A (<7 years) AID use, most frequent
- 10.3%-28.5%
- Increase in SAP and AID use, group B
- +15.8 PP
- Increase in SAP and AID use, group C
- +15.9 PP
Observational data: associations, not effects.
Further findings
HbA1c · 2018 to 2021
- HbA1c improved significantly in groups C and D
- both P < .01
Time in range (TiR) · 2018 to 2021
- TiR increase, group A
- +3 PP
- TiR increase, group B
- +5 PP
- TiR increase, group C
- +5 PP
- TiR increase, group D
- +5 PP
- P for each group
- P < 0.01
Technology use by sex
- Insulin pump use, females vs males
- 61.0% versus 53.4%
- SAP use, females vs males
- 33.5% versus 28.9%
Original publication
Use of Continuous Glucose Monitoring in Pump Therapy Sensor Augmented Pump or Automated Insulin Delivery in Different Age Groups (0.5 to <26 Years) With Type 1 Diabetes From 2018 to 2021: Analysis of the German/Austrian/Swiss/Luxemburg Diabetes Prospective Follow-up Database Registry. J Diabetes Sci Technol. Published 25 February 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →